Introducing Our Exciting New Report Features for 2024
»& Full access to influencer engagement stats
»& Free access to digital archives & 'MarketGlass' research platform. The proprietary platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. The state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
»& Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
»& Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
»& Complimentary report updates for one year
»& Competitor coverage with global market shares of major players
»& Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
»& Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes
What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.
Report Scope
The report analyzes the Liquid Filled Hard Capsules market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
- Segments: Capsule Type (Medium Capsules, Small Capsules, Large Capsules); End-Use (Pharma Companies & CMOs End-Use, Nutraceuticals & Dietary Supplement Manufacturers End-Use).
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Gelatin Raw Material segment, which is expected to reach US$619.5 Million by 2030 with a CAGR of 7.1%. The Hypromellose Capsules Raw Material segment is also set to grow at 4.2% CAGR for the next 7-year period.
- Regional Analysis: Gain insights into the U.S. market, valued at $150.9 Million in 2023, and China, forecasted to grow at an impressive 10.1% CAGR to reach $173.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Liquid Filled Hard Capsules Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Liquid Filled Hard Capsules Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Liquid Filled Hard Capsules Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as ABB Ltd., Air Liquide, Atlas Copco, Baker Hughes Company, Chart Industries and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 48 companies featured in this Liquid Filled Hard Capsules market report include:
- ACG Group- Altasciences- Bactolac Pharmaceutical- Biovencer Healthcare- Bright Pharma Caps- CapsCanada Corporation- Erawat Pharma Limited- Evonik Industries AG- Farmacapsulas S.A.- Fine USA Trading, Inc.- Fortcaps Healthcare Ltd.- Fuji Capsule- HealthCaps India Limited- Inlife Pharma Private Limited- Lonza Group (formerly Capsugel)- Natural Capsules Limited- Nectar Lifesciences Ltd. (NLL)- NextPharma- Qualicaps, Inc.- Roxlor, LLC- SuHeung Co., Ltd.- Sunil Healthcare
This edition integrates the latest global trade and economic shifts into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes historical analysis from 2015 to 2023.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ACG Group
- Altasciences
- Bactolac Pharmaceutical
- Biovencer Healthcare
- Bright Pharma Caps
- CapsCanada Corporation
- Erawat Pharma Limited
- Evonik Industries AG
- Farmacapsulas S.A.
- Fine USA Trading, Inc.
- Fortcaps Healthcare Ltd.
- Fuji Capsule
- HealthCaps India Limited
- Inlife Pharma Private Limited
- Lonza Group (formerly Capsugel)
- Natural Capsules Limited
- Nectar Lifesciences Ltd. (NLL)
- NextPharma
- Qualicaps, Inc.
- Roxlor, LLC
- SuHeung Co., Ltd.
- Sunil Healthcare
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 387 |
| Published | November 2025 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 549.2 Million |
| Forecasted Market Value ( USD | $ 842.1 Million |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |

